// App-Quantinova.ai

P2-02-02 : Predictors for discordance in HER2 phenotype between primary tumor and circulating tumor cells in women with metastatic breast cancer

Researchers

Presenter

  • Janni W

Principal Investigators

  • Schramm A

  • Friedl TWP

  • Muller V

  • Aktas B

  • Krawczyk N

  • Pantel K

  • Fehm T

  • Schochter F

  • Huober J

  • Rack B

  • Alunni-Fabbroni M

  • Fasching PA

  • Taran F-A

  • Hartkopf A

  • Schneeweiss A

Medical Centers

  • University Hospital Eppendorf Frauenklinik, Hamburg, Germany

  • Klinikum Augsburg, Ludwig-Maximilians-University, Munich, Germany

  • University of Tubingen, Tubingen, Germany

  • University of Ulm, Ulm, Germany

  • Heinrich-Heine-Universitat, Dusseldorf, Germany

  • University Medical Center Hamburg Eppendorf, Hamburg, Germany

  • University of Erlangen-Nuernberg, Erlangen, Germany

  • University Hospital of Essen, Essen, Germany

  • University Clinic Heidelberg, Heidelberg, Germany

Locations

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

Biomarkers

  • Circulating tumor cells

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved